Antidepressant treatment and smoking cessation in bipolar disorder

JAMA

Volumn 301, Issue 20, 2009, Pages 2093-

  Dervaux, Alain ^a   Laqueille, Xavier ^a  

^a CENTRE HOSPITALIER SAINTE ANNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ESCITALOPRAM; SERTRALINE; VENLAFAXINE; ANTIDEPRESSANT AGENT;

BIPOLAR DEPRESSION; BIPOLAR DISORDER; DRUG EFFICACY; DRUG SAFETY; HUMAN; LETTER; MANIA; PRIORITY JOURNAL; SMOKING CESSATION; TREATMENT RESPONSE; DRUG CONTRAINDICATION; NOTE; RISK; TOBACCO DEPENDENCE;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BIPOLAR DISORDER; BUPROPION; HUMANS; RISK; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 66149108795     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2009.705     Document Type: Letter

References (5)

1. Schroeder SA. A 51-year-old woman with bipolar disorder who wants to quit smoking. JAMA. 2009;301(5):522-531.
2. Sachs GS, Nierenberg AA, Calabrese JR, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med. 2007;356(17):1711-1722.
3. Post RM, Leverich GS, Nolen WA, et al; Stanley Foundation Bipolar Network. A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network. Bipolar Disord. 2003;5(6):396-406.
4. Leverich GS, Altshuler LL, Frye MA, et al. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry. 2006;163(2):232-239.
5. Prescribing information for Zyban (bupropion hydrochloride). GlaxoSmithKline Web site. http://us.gsk.com/products/assets/us-zyban.pdf. Accessed March 24, 2009.